ExhibitsA nurse is completing an admission assessment for a client. Which of the following medications should the nurse expect the provider to prescribe for the client? (Click on the exhibit tabs for additional information about the client. There are three tabs that contain separate categories of data.)

This client is a 68-year-old male with a history of heart failure and currently presents with elevated blood pressure and tachycardia. Management of heart failure focuses on reducing cardiac workload, controlling blood pressure, and improving cardiac efficiency. In this context, medications that reduce heart rate and myocardial oxygen demand are commonly indicated. Heart failure often requires beta-blocker therapy as part of long-term management to improve survival and prevent decompensation. Rationale: A. Febuxostat is used to treat hyperuricemia and gout by lowering serum uric acid levels. This client’s uric acid level is normal (4.5 mg/dL), so there is no indication for urate-lowering therapy. Additionally, there are no clinical findings suggesting gout or elevated uric acid that would warrant this medication. B. Levofloxacin is a broad-spectrum antibiotic used to treat bacterial infections. The client has a normal WBC count and no signs or symptoms of infection such as fever or elevated inflammatory markers. Therefore, there is no indication for antibiotic therapy in this clinical scenario. C. Atorvastatin is used for hyperlipidemia management and cardiovascular risk reduction. Although statins are commonly used in older adults, this client’s total cholesterol is within normal limits (189 mg/dL). There is no immediate indication provided for initiating lipid-lowering therapy based on the current data. D. Metoprolol is appropriate because it is a beta-blocker used in the management of heart failure and hypertension. The client has elevated blood pressure (152/94 mm Hg) and tachycardia (100/min), indicating increased cardiac workload. Metoprolol reduces heart rate, decreases myocardial oxygen demand, and improves cardiac efficiency, making it an appropriate expected prescription.